Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Apollo Care Recalls Antibiotic Injections
05/26/2023
Jolynn Tumolo
A Class II recall has been issued for several lots of vancomycin injection.
A Class II recall has been issued for several lots of vancomycin injection.
A Class II recall has been...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Advertisement

News
Effectively Improving the Management of Respiratory Diseases in Children
05/23/2023
Julie Gould
A recent study determined that a new test could be a valuable tool for diagnosing human adenovirus respiratory infections among children.
A recent study determined that a new test could be a valuable tool for diagnosing human adenovirus respiratory infections among children.
A recent study determined that a...
05/23/2023
Pharmacy Learning Network
News
RSV More Severe Than Influenza in Hospitalized Older Adults
05/22/2023
Jolynn Tumolo
Research suggests that RSV in hospitalized older adults is more severe than influenza but less severe than SARS-CoV-2. 
Research suggests that RSV in hospitalized older adults is more severe than influenza but less severe than SARS-CoV-2. 
Research suggests that RSV in...
05/22/2023
Pharmacy Learning Network
News
Study Details Prevalence of RSV in Older Adults
05/18/2023
Jolynn Tumolo
In a prospective cohort study, researchers investigated how many adults aged 50 years and older contracted respiratory syncytial virus (RSV) during two consecutive RSV seasons.
In a prospective cohort study, researchers investigated how many adults aged 50 years and older contracted respiratory syncytial virus (RSV) during two consecutive RSV seasons.
In a prospective cohort study,...
05/18/2023
Pharmacy Learning Network

Advertisement

News
Osteoporosis Nasal Spray Recalled
05/17/2023
Jolynn Tumolo
A Class II recall has been issued for more than 82,000 bottles of prescription nasal spray due to the presence of foreign substances.
A Class II recall has been issued for more than 82,000 bottles of prescription nasal spray due to the presence of foreign substances.
A Class II recall has been...
05/17/2023
Pharmacy Learning Network
News
Nerve Pain, Seizure Drug Recalled
05/17/2023
Jolynn Tumolo
A recall has been issued for almost 4000 cartons of gabapentin tablets distributed throughout the United States due to contamination.
A recall has been issued for almost 4000 cartons of gabapentin tablets distributed throughout the United States due to contamination.
A recall has been issued for...
05/17/2023
Pharmacy Learning Network
News
Class I Recall for Pneumonia Medication
05/17/2023
Jolynn Tumolo
A Class I recall has been issued for bottles of atovaquone oral suspension distributed throughout the United States.
A Class I recall has been issued for bottles of atovaquone oral suspension distributed throughout the United States.
A Class I recall has been issued...
05/17/2023
Pharmacy Learning Network

Advertisement

News
OTC Pain Relievers Recalled
05/12/2023
Jolynn Tumolo
A Class II recall has been issued for an over-the-counter pain reliever for being stored outside of labeled temperature requirements before being distributed across the United States.
A Class II recall has been issued for an over-the-counter pain reliever for being stored outside of labeled temperature requirements before being distributed across the United States.
A Class II recall has been...
05/12/2023
Pharmacy Learning Network
News
Statin Tablets Recalled
05/11/2023
Jolynn Tumolo
A Class II recall has been issued for prescription statin medication because of deviations from Current Good Manufacturing Practices.
A Class II recall has been issued for prescription statin medication because of deviations from Current Good Manufacturing Practices.
A Class II recall has been...
05/11/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use